Family

Loading Family data...

• 15 United States
• 10 France
• 8 Japan
• 7 China
• 5 Korea
• 2 Other

Patent Owner(s)

Patent Owner	Address
KYORIN PHARMACEUTICAL CO LTD	TOKYO 101-8311

International Classification(s)

• A61K:PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOS....
• C07D:HETEROCYCLIC COMPOUNDS

• 2009 Application Filing Year
• A61K Class
• 10313 Applications Filed
• 6747 Patents Issued To-Date
• 65.43 % Issued To-Date

Inventor(s)

Inventor Name	Address	# of filed Patents	Total Citations
Asahina, Yoshikazu	Tochigi, JP	14	90
# of filed Patents : 14 Total Citations : 90
Fukuda, Yasumichi	Tochigi, JP	28	228
# of filed Patents : 28 Total Citations : 228
Matsui, Toshiyuki	Tochigi, JP	45	238
# of filed Patents : 45 Total Citations : 238
Murakami, Koji	Tochigi, JP	137	1136
# of filed Patents : 137 Total Citations : 1136
Ohata, Kohei	Tochigi, JP	11	58
# of filed Patents : 11 Total Citations : 58
Yokota, Kazuya	Tochigi, JP	17	263
# of filed Patents : 17 Total Citations : 263

Cited Art Landscape

Load Citation

• No Cited Art to Display

Loading Cited Art Landscape...

Patent Citation Ranking

• 0 Citation Count
• A61K Class

• 0 % this patent is cited more than
• 14 Age

Forward Cite Landscape

Load Citation

• No Forward Cites to Display

Loading Forward Cite Landscape...

Maintenance Fees

Fee	Large entity fee	small entity fee	micro entity fee	due date

Fee	Large entity fee	small entity fee	micro entity fee
Surcharge after expiration - Late payment is unavoidable	$700.00	$350.00	$175.00
Surcharge after expiration - Late payment is unintentional	$1,640.00	$820.00	$410.00

DATE PUBLISHED	PUBLICATION/PATENT NO.	PUBLICATION TYPE
November 08, 2011	US,8053465,B2   US8053465B2	GRANTED PATENT AS SECOND PUBLICATION
April 15, 2010	US,20100093825,A1   US20100093825A1	FIRST PUBLISHED PATENT APPLICATION

Full Text

US Patent No: 8053465

Bicycloester derivative

---

Abstract

---

SummaryNovel bicycloester derivatives and pharmaceutically acceptable salts thereof have high DPP-IV inhibitory activity.Solving MeansThe novel bicycloester derivatives are represented by the general formula (1):Pharmaceutically acceptable salts thereof are also included (Example: (2S,4S)-1-[[(N-(4-ethoxycarbonylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile)).

---

 

---

Description

---

Claims

---

Claims data not available

---

Legal Events

 

• STCH2015
• FP2015
• LAPS2015
• REMI2015
• FEPP2011
• I2011
• P2010
• F2009
• PD2004

Date	Code	Event	Description
Dec 07, 2015	STCH	INFORMATION ON STATUS: PATENT DISCONTINUATION	free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362
Nov 08, 2015	FP	LAPSED DUE TO FAILURE TO PAY MAINTENANCE FEE	Effective Date: Nov 08, 2015
Nov 08, 2015	LAPS	LAPSE FOR FAILURE TO PAY MAINTENANCE FEES
Jun 19, 2015	REMI	MAINTENANCE FEE REMINDER MAILED
Dec 09, 2011	FEPP	FEE PAYMENT PROCEDURE	free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY
Nov 08, 2011	I	Issuance
Apr 15, 2010	P	Published
Dec 08, 2009	F	Filing
Feb 05, 2004	PD	Priority Date